As a Senior Medical Director of Clinical Development at Wave Life Sciences, I lead the development of ASO medicines to reduce, restore or modulate proteins responsible for rare genetic diseases. I have a decade of experience in clinical research, development and commercialization, with a focus on rare diseases and immunology.I am passionate about developing medicines for patients with unmet medical needs, using cutting-edge technologies such as AI and innovative therapies. I have successfully designed, executed and managed clinical trials in diverse rare disease areas with an emphasis on neurodevelopment, neuro-oncology, neuromuscular and neurodegenerative disease working with cross-functional teams and external partners. I hold an MRCP from the Royal College of Physicians and an MFPM from the Faculty of Pharmaceutical Medicine.